Tuesday, December 08, 2015 10:35:23 PM
I don't believe, this late in the game when we are close to completing phase3 and given the data we have so far, that no decent investor is willing to invest. There are other smart investors.
I also believe that Linda as the CEO has a responsibility-- even more so than NW-- to vet the relationships with Leary, Ondra, etc and act accordingly. In doing her job, she found conflict of interest with both organizations. they were linked to her competitors, Ondra possibly to Cramer's Crew?!?!?!?!
If Linda would have gone along with this and they stole sensitive info and thoroughly undermined NWBO, the same people complaining now would be calling her every name in the book. She, as CEO, recognized the correctness of NW ideas and moved accordingly. She found the people/orgs he recommended we not what NWBO needed and moved accordingly. I see no problem with Linda.
I also believe that Linda as the CEO has a responsibility-- even more so than NW-- to vet the relationships with Leary, Ondra, etc and act accordingly. In doing her job, she found conflict of interest with both organizations. they were linked to her competitors, Ondra possibly to Cramer's Crew?!?!?!?!
If Linda would have gone along with this and they stole sensitive info and thoroughly undermined NWBO, the same people complaining now would be calling her every name in the book. She, as CEO, recognized the correctness of NW ideas and moved accordingly. She found the people/orgs he recommended we not what NWBO needed and moved accordingly. I see no problem with Linda.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
